DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION

10.1002/(SICI)1522-2675(20000412)83:4<739::AID-HLCA739>3.3.CO;2-V

1998, Biol Pharm Bull, 21, 245, 10.1248/bpb.21.245

1997, Ginseng Rev, 24, 1

10.1016/S0006-2952(99)00212-9

10.1248/bpb.25.743

10.1248/bpb.23.1481

10.1124/dmd.30.4.378

1997, J Chromatogr B Biomed Sci Appl, 689, 349, 10.1016/S0378-4347(96)00304-0

10.3122/jabfm.10.4.265

10.1016/S0006-2952(97)00193-7

1996, Drugs made in Germany, 39, 6

10.1055/s-2007-971425

10.4065/76.7.688

1997, Planta Med, 63, 436, 10.1055/s-2006-957729

10.1055/s-2006-957938

1999, Free Radic Res, 31, 569, 10.1080/10715769900301141

1990, Chem Pharm Bull, 38, 2859, 10.1248/cpb.38.2859

Kato H, Shimada F, Yano S, and Kanaoka M (1990) Determination of ginsenoside Rb1 in plasma of human after intake of red ginseng powder. Abstract of papers, 11th Symposium of the Medical Society for Red Ginseng Research, Kobe, Japan, p 36.

1983, Chem Pharm Bull, 31, 292, 10.1248/cpb.31.292

2000, J Nutr, 130, 2073S, 10.1093/jn/130.8.2073S

2001, J Korean Med Sci, 16, S28, 10.3346/jkms.2001.16.S.S28

Soldati F (2000) Panax ginseng standardization and biological activity, in Biologically Active Natural Products: Pharmaceuticals (Cutler SJ and Cutler HG eds) pp 209–232, CRC Press LLC, Boca Raton, FL.

1985, Acta Pharm Suec, 22, 113

2002, J Nutr, 132, 630, 10.1093/jn/132.4.630